Boer lean body weight equations

The calculator converts pounds to kilograms with 0.45359237 and inches to centimeters with 2.54. Sex selects the published equation coefficients. The model does not use age, diagnosis, body-fat measurement, kidney function, or a medication.

The labels “male” and “female” describe the variables in the original equations, not a complete account of sex, gender, hormones, body composition, or clinical dosing. For transgender and intersex patients, a clinician and pharmacist should select a validated method appropriate to the drug and patient rather than guessing which equation is safer.

Worked 70-inch, 220-pound male-equation example

Seventy inches converts to 177.8 centimeters. Two hundred twenty pounds converts to approximately 99.79 kilograms. The weight term is 0.407 × 99.79, or about 40.61. The height term is 0.267 × 177.8, or about 47.47.

Adding those terms and subtracting 19.2 gives approximately 68.89 kg, displayed as 68.9 kg or 151.9 lb. Dividing 68.89 by the actual 99.79 kg gives 69.0%. Subtracting the estimate from actual weight leaves 30.9 kg, an arithmetic remainder rather than a measured fat mass.

The male Devine ideal body weight at 5 feet 10 inches is 50 + 2.3 × 10 = 73.0 kg. Boer is about 4.1 kg lower in this example. Neither number is automatically the correct scalar for a particular medication.

What Boer originally estimated

P. Boer published the equations in 1984 while studying whether estimated lean body mass could normalize blood and extracellular fluid volumes. The study included 66 healthy subjects for blood volume and 54 for extracellular fluid volume. It concluded that the estimated lean-body-mass index behaved more consistently than several other size measures for those fluid-volume relationships.

The equations are therefore regression estimates derived from height and weight in a limited research population. They did not directly scan every modern body type, and the paper did not establish Boer weight as a universal medication-dosing rule.

Later clinical fields adopted lean body weight as one possible size descriptor because fat and lean tissues may affect drug distribution and clearance differently. That pharmacologic rationale must still be demonstrated for each medicine and regimen.

Four weight scalars are not interchangeable

Fat-free mass and lean body mass are also sometimes used as if identical, although definitions can differ regarding essential lipid. In dosing practice, the name in a protocol must be matched to its exact formula. Substituting Boer where a protocol specifies Janmahasatian, James, Devine, or adjusted body weight can change the result materially.

Why drug behavior cannot be inferred from one mass

Drug distribution depends on water solubility, lipid solubility, protein binding, tissue perfusion, and molecular properties. Clearance can depend on kidney filtration and secretion, liver blood flow and enzymes, transporters, critical illness, age, genetics, interacting drugs, and organ dysfunction.

A loading dose and maintenance dose may use different logic. A lipophilic drug may distribute into adipose tissue differently from a hydrophilic drug. Total body weight may be appropriate for one medication, while lean or adjusted weight may be studied for another. Fixed dosing may be preferred when size does not explain clinically important variability.

Therapeutic drug monitoring, pharmacodynamic response, kidney-function equations, and adverse-effect surveillance can matter more than the initial weight scalar. The Boer output supplies none of those checks.

Limitations at body-size extremes

Linear equations can produce implausible relationships at very short, tall, low-weight, or high-weight extremes. A 2015 analysis argued that lean body weight is not a universally valid dosing scalar in morbid obesity. More recent drug-specific reviews often prefer other formulas or emphasize that evidence remains incomplete.

Edema, ascites, pregnancy, amputation, dehydration, large tumors, critical illness, and rapid weight change can separate scale weight from stable tissue composition. The formula cannot recognize those conditions. Athletic muscularity and age-related sarcopenia can also make two people with identical height and weight biologically different.

If the estimate exceeds actual weight, the calculator still exposes the arithmetic problem instead of silently capping it. Clinicians should verify the measurements and use an appropriate method rather than interpreting the equation literally.

Use current, traceable measurements

Measure standing height without shoes when safe. Use a calibrated scale and record clothing, equipment, prostheses, and timing when relevant. Do not rely on a driver’s-license height or a remembered weight for a high-risk decision.

Convert units once and retain the unrounded metric values. A common error is entering pounds as kilograms, which more than doubles the weight term. Another is entering feet in a field expecting inches. This calculator labels U.S. units explicitly and shows conversions for checking.

Document the equation version, selected sex coefficient set, height, weight, source date, and output. In clinical care, calculations belong in approved systems with patient identification and privacy controls, not in a public web form.

How to approach a medication question safely

Start with the current FDA-approved prescribing information and an institution’s current formulary or protocol. Identify whether the instruction says actual, ideal, lean, adjusted, dry, or another weight. Check whether the method changes by obesity category, age, renal replacement therapy, dialysis, indication, route, or treatment phase.

Verify renal and hepatic function, allergies, interactions, pregnancy or lactation, previous doses, concentration, infusion rate, maximum single and daily doses, and required monitoring. High-alert medicines may require an independent double check.

If a source merely says “dosing weight” without defining it, stop and clarify. Do not choose Boer because a calculator is available. A pharmacist is especially valuable when evidence conflicts or the patient lies outside study populations.

Body composition and longitudinal change

Boer weight may change when actual weight changes even if height is fixed. The equation attributes a fixed fraction of weight change to lean mass according to its sex-specific coefficient. That mathematical movement is not proof that measured muscle or organ mass changed by the same amount.

Dual-energy X-ray absorptiometry, bioimpedance, air displacement, imaging, and other methods estimate body composition differently and have their own errors. If the clinical question is sarcopenia, nutrition, or body composition—not a named Boer-based protocol—use a validated assessment appropriate to that purpose.

Do not use daily Boer fluctuations as a weight-loss target. A health plan should consider strength, function, nutrition, cardiometabolic measures, symptoms, and professional guidance.

Boer calculation checklist

1. Confirm the formula is actually requested.
2. Use measured adult height.
3. Use current measured weight.
4. Record original U.S. units.
5. Convert pounds to kilograms.
6. Convert inches to centimeters.
7. Select the published coefficient set deliberately.
8. Keep full internal precision.
9. Label output as estimated LBW.
10. Do not call the remainder measured fat.
11. Do not substitute LBW for IBW.
12. Verify drug-specific dosing guidance.
13. Check organ function and dose caps.
14. Use pharmacist or prescriber review.

It does not determine prescription cost, coverage, medical deductions, medication selection, or dosing weight.

Frequently asked questions

References

• Boer, Estimated lean body mass as an index for normalization of body fluid volumes
• Lean body mass as a predictor of drug dosage
• Lean Body Weight Is Not a Weight Scalar for Estimating Drug Doses in Morbid Obesity
• Boer versus James lean-weight contrast injection study
• Drug dosing in obese adults
• Updated antimicrobial dosing recommendations for patients with obesity